A slightly disappointing 2nd quarter for DC-area VC deals

The country has been blessed with yet another $1 billion venture capital investment in the second quarter — but meanwhile, the D.C. area economy hasn’t seen much of an uptick, according to the quarterly MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association.
Despite a 30 percent increase from the first quarter in VC investments nationwide, the area spanning D.C., West Virginia, Virginia and Maryland saw a slight slump in funding in the second quarter.
From April to June, venture capitalists invested $245 million in the region — a 26 percent decrease from the first quarter and slightly lower than the $248 million invested in the same time period last year.
The biotechnology industry edged out software companies by about $3 million, earning $89 million in VC funding. That’s the first time biotech firms outraised software companies since the second quarter of 2013.
The 10 biggest deals in the greater D.C. metro area this past quarter were:

1. Rockville-based Regenxbio: $70.5 million
2. D.C.-based Mapbox: $52.6 million
3. Arlington-based Distil Networks: $21 million
4. Rockville-based OriGene Technologies: $17 million
5. Rockville-based C.A.V.A.: $16 million
6. Bethesda-based Aledade: $15 million
7. Reston-based Footage Firm: $8 million
8. Lanham-based Framebridge: $7.7 million
9. D.C.-based Full Measure Education: $5.5 million
10. Arlington-based Brazen: $4.7 million